Clinical Trial Update: Thymectomy Trial in Non-Thymomatous Myasthenia Gravis Patients Receiving Prednisone Therapy [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluated thymectomy in non-thymomatous myasthenia gravis patients receiving prednisone, and the results have been posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myasthenia Gravis

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Myasthenia Gravis | Phase 3 | Status: COMPLETED | Results posted: 2017-01-16